Former State of Wisconsin Investment Board portfolio manager Carrie J. Thome has been named director of investments at the Wisconsin Alumni Research Foundation, where she will manage a $1.8 million investment portfolio. Income and gains from the portfolio are gifted to the University of Wisconsin-Madison...
The Wisconsin Governor's Business Plan Contest is accepting entries online for the 2008 competition. Entries for the first statewide, tech-based business plan competition will be accepted now through 5 p.m. on Jan. 31, 2008. ...
A team led by University of Wisconsin-Madison biochemistry and nutritional sciences professor James Ntambi reports that SCD-1, a gene in the liver, causes mice to gain weight on a diet laden with carbohydrates. Writing in the December issue of Cell Metabolism, Ntambi said the gene...
During the 1990s, the rush by Big Pharma to enhance patient compliance involved going from regular dosage release to controlled release. According to columnist Michael Rosen, this mechanism allowed for better patient compliance and also afforded some additional patent protection and product life. In this...
If Dane County is any indication, the economy may not be that bad after all. An annual survey in Wisconsin's fastest-growing county demonstrates resilience to a possible economic downturn in 2008. This is especially true of the technology sector, which reported strong numbers in terms...
Dr. James Thomson of the University of Wisconsin-Madison will speak on “Stem cell research: The Next Chapter" at the Jan. 22 luncheon meeting of the Wisconsin Innovation Network in Madison. A team led by Thomson recently discovered a way to produce embryonic stem cells from...
Stratatech Corp., a Madison-based regenerative medicine company, has been awarded a $975,000 “fast-track” SBIR grant from the National Institute on Aging. The grant will allow Stratatech to accelerate its development of wound-care products....
Quintessence Biosciences will receive two Phase I small business innovation research grants totaling more than $280,000 for the continued development of cancer-fighting drugs. The Madison biotechnology company, which is preparing its lead drug candidate, will use the grants to develop second generation anti-cancer products....
For those who wonder if all this new scientific collaboration is really beneficial, the recent stem cell discovery should provide ample proof, according to columnist Tom Still. In this edition of Inside Wisconsin, Still notes that collaboration has born fruit with NimbleGen's laboratory and production...
The recent discovery by scientists in Wisconsin and Japan not only resolves ethical issues associated with embryonic stem cell research, it will lead to more practical and effective stem cell research, according to the executive director of Wisconsin Right to Life. In this guest column...